To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.
GFI submitted comments to FDA pushing back on the National Milk Producers Federation's proposal to label plant-based dairy products as “imitation” milk.
GFI's comment supports a cautious and flexible approach towards labeling as cultivated seafood comes to market. Learn why we support regulatory flexibility for cultivated seafood.
GFI urges FDA to establish principles for modernizing food standards that account for all foods. Learn why doing so is vital to FDA’s goal of supporting innovation.
GFI’s supplement highlights market developments since submitting its Citizen Petition. Learn why the developments demonstrate a need for clarity from FDA.
GFI’s comment encourages FDA to clarify that new foods may be named by reference to the names of other foods. Learn why doing so supports FDA’s goal of promoting innovation.
GFI’s comment discusses the role labels serve on plant-based dairy products. Learn why FDA should not restrict plant-based dairy’s clear labels.
GFI’s comment applauds USDA and FDA’s commitment to working together to ensure the safety of cultivated meat. Learn why we support the joint regulatory framework.
GFI’s comment requests FDA to clarify the role of standards of identity. Learn how flexible standards support innovation and consumer choice.
GFI’s comment explains the need for a clear regulatory pathway for cultivated meat. Learn more about cultivated meat and why FDA is well situated to ensure its safety.